TY  - CONF

T1  - Efficacy and safety of tralokinumab in adolescents with moderate-to- severe atopic dermatitis: results of the phase 3 ECZTRA 6 trial

JO  - SKIN The Journal of Cutaneous Medicine

PY  - 2022/03/04

AU  - Paller A

AU  - Blauvelt A

AU  - Soong W

AU  - Imafuku S

AU  - Hong C-H

AU  - Schuttelaar M

AU  - Amoudruz P

AU  - Kurbasic A

AU  - Soldbro L

AU  - Lophaven K

AU  - Cork M et al

ED  - 

DO  - DOI: 10.25251/skin.6.supp.s29

PB  - National Society for Cutaneous Medicine

VL  - 6

IS  - 2

SP  - s29

EP  - s29

Y2  - 2024/12/22

ER  -